The study’s results reveal a novel idea for treating Alzheimer’s disease and other neurological illnesses by employing thermoresponsive and biodegradable linear–dendritic nanoparticles for the thermally targeted and sustained release of NGF and other protein therapeutics [143]. Here, NGF is linked to Alzheimer disease.